Advertisement
UK markets open in 3 hours 19 minutes

  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     

  • HANG SENG

    17,317.00
    +115.73 (+0.67%)
     

  • CRUDE OIL

    82.80
    -0.01 (-0.01%)
     

  • GOLD FUTURES

    2,320.60
    -17.80 (-0.76%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,673.70
    -1,797.42 (-3.36%)
     

  • CMC Crypto 200

    1,388.57
    -35.53 (-2.50%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

New Strong Sell Stocks for March 11th

Zacks Equity Research
·1-min read

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Digi International Inc. DGII provides business and mission-critical Internet of Things products, services, and solutions. The Zacks Consensus Estimate for its current year earnings has been revised 9.5% downward over the last 30 days.

Independence Realty Trust, Inc. IRT is a real estate investment trust that owns and operates multifamily apartment properties. The Zacks Consensus Estimate for its current year earnings has been revised 3.6% downward over the last 30 days.

IVERIC bio, Inc. ISEE is a biopharmaceutical company that develops novel therapies to treat ophthalmic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 4% downward over the last 30 days.

ADVERTISEMENT

Palatin Technologies, Inc. PTN is a specialized biopharmaceutical company that develops targeted receptor-specific therapeutics for the treatment of various diseases. The Zacks Consensus Estimate for its current year earnings has been revised 55.6% downward over the last 30 days.

VistaGen Therapeutics, Inc. VTGN is a clinical-stage biopharmaceutical company that engages in developing and commercializing various medicines. The Zacks Consensus Estimate for its current year earnings has been revised 21.1% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Palatin Technologies, Inc. (PTN) : Free Stock Analysis Report
 
Independence Realty Trust, Inc. (IRT) : Free Stock Analysis Report
 
IVERIC bio, Inc. (ISEE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research